ID   JHUEM-14
AC   CVCL_4654
SY   JHUEM14
DR   CLO; CLO_0050877
DR   BioSample; SAMN03472023
DR   RCB; RCB2225
DR   Wikidata; Q54898913
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB2225
ST   Amelogenin: X
ST   CSF1PO: 12,13,14
ST   D13S317: 8,10
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,10
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
RX   PubMed=29872505; DOI=10.18632/oncotarget.25349; PMCID=PMC5973852;
RA   Takeshita S., Yamashita Y., Shiomi K., Suzuki N., Yoshida J.,
RA   Naiki-Ito A., Suzuki S., Akatsuka S., Toyokuni S., Takahashi T.,
RA   Mase S., Arakawa A., Sugiura-Ogasawara M., Takahashi S.;
RT   "Expression of P-REX2a is associated with poor prognosis in
RT   endometrial malignancies.";
RL   Oncotarget 9:24778-24786(2018).
//